Newsroom | 26644 results

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report on Form 10-K for the years ended December 31, 2023 and 2024 (the “2023 and 2024 Form 10-K”) with the Securities and Exchange Commission (“SEC”). “In our previous shareholder update, I framed a critical must-do to get current and stay current on our SEC filings. Today marks a major milestone in tha...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation, Inc. (NASDAQ: PODD) (“Insulet” or the “Company”) today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omnipod DASH®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery. This action is separate from the voluntary Medical Device Correction issued on March 12, 2026 affecting certain Omn...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on May 15, 2026, an inducement grant (the “Inducement Grant”) was made to Anthony Catalano in connection with the commencement of his employment as the Chief Operating Officer of the Company. The Inducement Grant consists of restricted stock units (“RSUs”) covering 141...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker-driven solutions for multiple sclerosis, Parkinson's and other neurodegenerative diseases, today announced the appointment of Zachary Fernandes as Vice President, Business Development. He will lead Octave’s partnership strategy focused on driving durable revenue growth through transformative, strategic collaborations across the life sciences ecosystem. Mr. Fernandes h...

EVANSTON, Ill.--(BUSINESS WIRE)--ZS, a global management consulting and technology firm, has been named a Leader in the IDC MarketScape: Worldwide Life Sciences R&D Strategic Consulting Services 2026 Vendor Assessment (IDC #US53009826, May 2026). The IDC MarketScape evaluates life sciences R&D strategic consulting providers based on their capabilities and strategies, assessing how well vendors support areas such as R&D operating model design, data and digital health strategy, AI-ena...

GOTHENBURG, Svezia--(BUSINESS WIRE)--Oticon Medical oggi presenta Ponto Instant, il suo nuovo portafoglio non chirurgico progettato per ampliare l'accesso alle soluzioni per l'udito a conduzione ossea e offrire una maggior scelta agli utenti e ai professionisti del settore. La linea di prodotti Ponto Instant comprende Softband 5, la comprovata e affidabile soluzione non chirurgica targata Oticon Medical, e ora si arricchisce con il lancio di Instant HearBand e Instant SoundConnector, per consol...

GÖTEBORG, Zweden--(BUSINESS WIRE)--Oticon Medical kondigt vandaag Ponto Instant aan, de nieuwe niet-chirurgische portfolio van het bedrijf ontworpen om toegang tot hooroplossingen met beengeleiding te verruimen en gebruikers en hoorzorgprofessionals meer keuze te bieden. De Ponto Instant-portfolio omvat de Softband 5, de bewezen en vertrouwde niet-chirurgische oplossing van Oticon Medical, en wordt nu uitgebreid met de lancering van de Instant HearBand en Instant SoundConnector, waarmee het aan...

GÖTEBORG, Suède--(BUSINESS WIRE)--Oticon Medical annonce aujourd’hui sa nouvelle gamme de solutions non chirurgicales, Ponto Instant, conçue pour élargir l’accès à l’audition par conduction osseuse et offrir davantage de choix aux utilisateurs et aux audioprothésistes. La gamme Ponto Instant comprend Softband 5, la solution non chirurgicale éprouvée et reconnue d’Oticon Medical, et s’enrichit désormais avec le lancement d’Instant HearBand et d’Instant SoundConnector, renforçant ainsi son offre...

Gotemburgo, Suecia--(BUSINESS WIRE)--Oticon Medical presenta hoy su nueva gama de productos no quirúrgicos, Ponto Instant, diseñada para ampliar el acceso a los audífonos de conducción ósea y ofrecer más opciones a los pacientes y a los profesionales de la audición. La gama Ponto Instant incluye Softband 5, la solución no quirúrgica consolidada y de confianza de Oticon Medical, y ahora se amplía con el lanzamiento de Instant HearBand e Instant SoundConnector, lo que refuerza aún más su oferta d...

GÖTEBORG, Schweden--(BUSINESS WIRE)--Oticon Medical gibt heute die Einführung seines neuen Portfolios an nicht-chirurgischen Lösungen, Ponto Instant, bekannt, das den Zugang zu Hörgeräten mit Knochenleitung erweitern und Anwendern sowie Hörakustikern mehr Auswahl bieten soll. Das Ponto-Instant-Portfolio umfasst Softband 5, die bewährte und vertrauenswürdige nicht-chirurgische Lösung von Oticon Medical, und wird nun durch die Einführung von Instant HearBand und Instant SoundConnector erweitert,...